EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Segmental Glomerulosclerosis Subclassification in the Oxford Classification System (MEST-C) Improves the International IgA Nephropathy Prediction Tool

Yingting Du iD, Fang Lu, Zixuan Wang, Zihuan Qiu, Yifei Lu, Hua Shu, Yiyang Xu, Shan Hou, Zitao Wang, Bo Zhang iD, Changying Xing, Suyan Duan und 2 weitere

Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 4036

DOI: 10.3390/jcm15114036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Yingting Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province of China, Jiangsu Provincial Authorities Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early external validation studies demonstrated the robust and consistent predictive performance of the International IgA Nephropathy Prediction Tool (IIgAN-PT) across diverse ethnic populations. However, emerging evidence suggests that, in contemporary cohorts of patients with IgA nephropathy, the IIgAN-PT increasingly tends to overestimate the risk of adverse renal outcomes. Subclassification of segmental glomerulosclerosis (S lesions) in the Oxford Classification system (MEST-C) could identify high-risk IgAN patients, with evidence that different S subclassifications respond differently to treatment. Our study aimed to evaluate the predictive performance of the IIgAN-PT in a contemporary Chinese external validation cohort and to optimize its prognostic accuracy by incorporating the most severe and prevalent pathological subclassification of S lesions, NOS+Adh+, into the original model.

Methods

A total of 746 Chinese patients were included with biopsy-proven IgAN in this study. Major adverse kidney events (MAKEs) were defined as death from any cause, initiation of renal replacement therapy, or a 50% decline in eGFR. This study evaluated the discrimination and model fit of three predictive models. The performance of the original and modified IIgAN-PT models was compared and evaluated through reclassification, survival analysis, calibration, decision curve analyses and subgroup analyses.

Results

In the study cohort, the median follow-up duration was 4.2 years, during which 77 patients experienced MAKEs. The discriminative ability of the three original models was relatively limited. In contrast, the modified IIgAN-PT incorporating the NOS+Adh+ subtype of S subclassification demonstrated improved global performance for predicting 5-year risk, achieving a C-index of 0.808 (95% CI, 0.756–0.861). Kaplan–Meier survival curves showed clear risk stratification, particularly between low- and intermediate-risk categories. Reclassification analyses (continuous NRI and IDI) and decision curve analysis further supported enhanced predictive performance, while calibration curves corrected the original model’s risk overestimation. The modified model maintained stable performance across clinically relevant subgroups, including patients with hypertension, proteinuria, or receiving immunosuppression.

Conclusions

This study further confirms the independent and clinically relevant prognostic value of the S pathological subclassification. The modified IIgAN-PT model, incorporating the NOS+Adh+ subtype of S subclassification, demonstrated consistent performance in individualized risk assessment for patients with IgA nephropathy.

Schlagwörter

Stichwörter der Autor:innen

IgA nephropathyS subclassificationinternational prediction toolprediction modelprognosis

Autor:innen und Institutionen

  • Department of Nephrology, the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.

ORCID-Profile: Yingting Du, Bo Zhang, Huijuan Mao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province of China
  • Jiangsu Provincial Authorities Hospital
  • First Affiliated Hospital with Nanjing Medical University, and Jiangsu Provincial Medical Key Discipline (Laboratory) Cultivation Unit

Zitieren

APA

Du, Y., Lu, F., Wang, Z., Qiu, Z., Lu, Y., Shu, H., Xu, Y., Hou, S., Wang, Z., Zhang, B., Xing, C., Duan, S., Mao, H., & Yuan, Y. (2026). Segmental Glomerulosclerosis Subclassification in the Oxford Classification System (MEST-C) Improves the International IgA Nephropathy Prediction Tool. Journal of Clinical Medicine, 15(11), 4036. https://doi.org/10.3390/jcm15114036

Vancouver

Du Y, Lu F, Wang Z, Qiu Z, Lu Y, Shu H, et al. Segmental Glomerulosclerosis Subclassification in the Oxford Classification System (MEST-C) Improves the International IgA Nephropathy Prediction Tool. Journal of Clinical Medicine. 2026;15(11):4036. doi:10.3390/jcm15114036

BibTeX
@article{Du2026,
  author = {Du, Yingting and Lu, Fang and Wang, Zixuan and Qiu, Zihuan and Lu, Yifei and Shu, Hua and Xu, Yiyang and Hou, Shan and Wang, Zitao and Zhang, Bo and Xing, Changying and Duan, Suyan and Mao, Huijuan and Yuan, Yanggang},
  title = {Segmental Glomerulosclerosis Subclassification in the Oxford Classification System (MEST-C) Improves the International IgA Nephropathy Prediction Tool},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {4036},
  doi = {10.3390/jcm15114036}
}
Kostenlos starten →